title: Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.).
authors.forename: Haralampos J
authors.initials: HJ
authors.lastname: Milionis
authors.forename: Moses S
authors.initials: MS
authors.lastname: Elisaf
mesh_terms: D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D000069059:Atorvastatin; D004359:Drug Therapy, Combination; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009525:Niacin / Q000008:administration & dosage*; D011758:Pyrroles / Q000008:administration & dosage*; D019821:Simvastatin / Q000008:administration & dosage*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D009525:Niacin; D000069059:Atorvastatin; D019821:Simvastatin